2019. Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn’s disease: what are the reasons for differences from previous studies?. Clinics. 74, (Oct. 2019), e1517. DOI:https://doi.org/10.6061/clinics/2019/e1517.